Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000.

Andrew Robert Ness, Andrea Waylen, Katrina Hurley, Mona Jeffreys, Chris Penfold, Miranda Pring, Sam Leary, Christine Allmark, Stu Toms, Susan Ring, Tim J Peters, Will Hollingworth, Helen Worthington, Chris Nutting, Sheila Fisher, Simon N Rogers, Steven J Thomas

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Head and neck cancer is an important cause of ill health with rapidly changing aetiology. Survival appears to have improved but the reasons for this are unclear. Adequately-powered, longitudinal studies in people with head and neck cancer are required. We recruited 5511 people with head and neck cancer to a large DNA-backed clinical cohort. Multi-centre clinical cohort studies in head and neck cancer are feasible in the UK. This article is protected by copyright. All rights reserved.

    Fingerprint

    Dive into the research topics of 'Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000.'. Together they form a unique fingerprint.

    Cite this